1. Home
  2. LCTX vs XFLT Comparison

LCTX vs XFLT Comparison

Compare LCTX & XFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$0.79

Market Cap

251.4M

Sector

Health Care

ML Signal

N/A

Logo XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest

XFLT

XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest

N/A

Current Price

$15.23

Market Cap

250.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LCTX
XFLT
Founded
1990
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
251.4M
250.4M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
LCTX
XFLT
Price
$0.79
$15.23
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $5.50
N/A
AVG Volume (30 Days)
★ 2.1M
107.1K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
★ 14.17%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $14,556,000.00
N/A
Revenue This Year
$4.38
N/A
Revenue Next Year
$10.80
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 53.24
N/A
52 Week Low
$0.77
$3.02
52 Week High
$1.99
$19.63

Technical Indicators

Market Signals
Indicator
LCTX
XFLT
Relative Strength Index (RSI) 34.81 24.45
Support Level N/A $3.05
Resistance Level $1.16 $19.53
Average True Range (ATR) 0.08 0.35
MACD -0.03 0.02
Stochastic Oscillator 2.86 1.32

Price Performance

Historical Comparison
LCTX
XFLT

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

About XFLT XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest

XAI Octagon Floating Rate & Alternative Income Trust is a diversified, closed-end management investment company which invests in a dynamically managed portfolio of floating-rate credit instruments and other structured credit investments within the private markets. The Trust's investment objective is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle.

Share on Social Networks: